bronchiol
common
caus
hospit
among
infant
limit
effect
convent
medic
prompt
use
complementari
altern
medicin
cam
altern
adjunct
therapi
manag
bronchiol
review
identifi
studi
random
control
trial
cohort
studi
examin
four
herbal
prepar
four
supplement
use
either
adjunct
altern
therapi
bronchiol
infant
studi
moder
qualiti
among
six
studi
report
length
stay
signific
benefit
found
chines
herbal
medicin
compar
ribavirin
one
cohort
studi
n
vitamin
compar
placebo
one
random
control
trial
n
studi
chines
herbal
medicin
studi
n
vitamin
studi
n
nacetylcystein
studi
n
magnesium
bronchiol
common
acut
lower
respiratori
tract
infect
viral
origin
among
infant
character
cough
rhinorrhea
crackl
wheez
fever
hypoxemia
common
etiolog
includ
respiratori
syncyti
viru
rhinoviru
adenoviru
coronaviru
human
metapneumoviru
influenza
parainfluenza
econom
social
implic
bronchiol
substanti
north
america
hospit
attribut
bronchiol
increas
twofold
past
two
decad
diseas
current
account
thousand
hospit
admiss
annual
estim
cost
billion
unit
kingdom
infant
develop
bronchiol
first
year
life
infant
requir
hospit
admiss
england
alon
secondari
care
admiss
bronchiol
despit
decad
research
effect
pharmacotherapi
bronchiol
still
lack
current
treatment
controversi
definit
recommend
use
drug
routin
manag
bronchiol
common
pharmacolog
agent
bronchodil
corticosteroid
hyperton
salin
shown
provid
symptomat
relief
maintain
hydrat
oxygen
patient
remain
cornerston
manag
absenc
efficaci
cur
therapi
use
complementari
altern
medicin
cam
bronchiol
gain
popular
past
year
sever
studi
examin
effect
differ
cam
bronchiol
make
sens
literatur
requir
comprehens
systemat
synthesi
avail
evid
aim
current
studi
comprehens
apprais
effect
safeti
cam
treatment
bronchiol
infant
search
strategi
construct
use
combin
keyword
includ
altern
medicin
complementari
medicin
herbal
medicin
herb
tradit
medicin
chines
medicin
chines
tradit
asian
tradit
altern
therapi
complementari
therapi
herbal
therapi
tradit
therapi
supplement
antioxid
vitamin
natur
homeopathi
kinesiolog
kinesiotherapi
osteopath
medicin
osteopath
manipul
bronchiol
text
complement
addit
search
bibliographi
relev
primari
review
articl
articl
includ
met
follow
criteria
random
control
trial
prospect
cohort
studi
publish
english
chines
languag
avail
fulltext
investig
use
form
complementari
altern
medicin
defin
nation
center
complementari
integr
health
nccih
group
divers
medic
health
care
system
practic
product
gener
consid
part
convent
medicin
either
singl
agent
adjunct
therapi
comparison
group
either
placebo
therapi
involv
inpati
outpati
age
one
month
two
year
clinic
diagnos
bronchiol
two
investig
kpk
swhl
independ
screen
titl
abstract
full
text
relev
articl
retriev
review
independ
determin
elig
inclus
review
disagr
resolv
discuss
data
regard
studi
design
particip
intervent
clinic
outcom
advers
event
independ
abstract
two
investig
kpk
swhl
use
standard
data
collect
form
also
contact
five
correspond
author
addit
inform
two
respons
receiv
two
investig
kpk
swhl
independ
assess
methodolog
qualiti
random
control
trial
use
cochran
risk
bia
assess
tool
cover
seven
domain
random
sequenc
gener
select
bia
alloc
conceal
select
bia
blind
particip
personnel
perform
bia
blind
outcom
assessor
detect
bia
incomplet
outcom
data
attrit
bia
select
report
report
bia
auxiliari
domain
bia
cohort
studi
newcastleottawa
qualiti
assess
scale
use
evalu
studi
methodolog
base
upon
three
paramet
select
particip
compar
cohort
basi
design
analysi
outcom
ascertain
disagr
resolv
consensu
two
investig
kpk
swhl
predefin
primari
outcom
length
hospit
stay
secondari
outcom
includ
time
resolut
bronchiol
symptom
advers
event
clinic
outcom
report
includ
studi
clinic
sever
score
rate
cure
oxygen
satur
bronchiol
symptomatolog
present
treatment
period
durat
fluid
nutrit
replac
use
oxygen
supplement
use
respiratori
support
characterist
result
includ
studi
summar
tabul
descript
analysi
perform
studi
investig
kpk
swhl
result
present
narr
data
extract
calcul
rel
risk
rr
dichotom
outcom
mean
differ
md
continu
outcom
associ
confid
interv
ci
pvalu
random
effect
model
use
review
manag
revman
softwar
version
studi
report
data
median
respect
median
valu
pvalu
present
accordingli
probabl
consid
statist
signific
metaanalysi
perform
due
variabl
differ
outcom
assess
studi
design
cam
intervent
use
initi
search
yield
studi
underw
fulltext
evalu
uniqu
studi
includ
review
fig
compris
random
control
trial
cohort
studi
conduct
asia
enrol
total
inpati
infant
present
bronchiol
sampl
size
studi
vari
particip
age
rang
month
studi
publish
english
n
chines
n
languag
four
studi
multicent
seven
singlecent
studi
durat
rang
one
day
one
week
studi
bronchiol
diagnos
physician
base
symptom
acut
wheez
respiratori
distress
seven
studi
infant
diagnos
first
time
wheezer
anoth
one
studi
recruit
combin
wheez
nonwheez
patient
specif
inform
provid
three
studi
tabl
three
studi
fund
univers
govern
agenc
whilst
eight
studi
sponsorship
main
characterist
result
includ
studi
summar
tabl
clinic
diagnos
symptom
cough
episod
pant
chest
oppress
emphysema
case
rale
wheez
low
fever
gupta
p
acut
onset
rapid
breath
wheez
andor
crackl
young
infant
prodrom
upper
respiratori
catarrh
intervent
four
herbal
prepar
four
supplement
examin
includ
chines
herbal
medicin
herbal
mixtur
herbal
monoprepar
vitamin
nacetylcystein
zinc
magnesium
five
studi
compar
placebo
treatment
whilst
anoth
six
studi
activ
compar
ribavirin
salbutamol
epinephrin
convent
care
cephalosporin
aminophyllin
oxygen
chines
herbal
medicin
xiao
er
ke
chuan
ling
commonli
report
outcom
durat
hospit
stay
n
studi
time
symptom
resolut
n
studi
cure
rate
n
studi
clinic
sever
score
hospit
n
studi
random
control
trial
methodolog
qualiti
random
control
trial
rct
gener
moder
three
trial
domain
judg
low
risk
bia
trial
appropri
method
random
well
alloc
conceal
seven
studi
mention
doubl
blind
three
describ
detail
blind
patient
personnel
outcom
assessor
studi
judg
suffici
report
outcom
low
risk
bia
select
outcom
report
howev
studi
unclear
risk
sourc
bia
fig
cohort
studi
observ
studi
feng
colleagu
lack
methodolog
detail
qualiti
assess
two
studi
gener
good
qualiti
cohort
select
compar
independ
blind
outcom
assess
adequaci
follow
describ
chines
herbal
medicin
four
differ
prepar
chines
herbal
medicin
examin
herbal
composit
medicin
properti
respect
chines
herbal
medicin
describ
tabl
mechan
action
herbal
medicin
present
tabl
shuang
huang
lian
cohort
studi
wang
et
al
n
author
examin
use
shuang
huang
lian
inject
found
signific
decreas
length
hospit
stay
md
day
ci
p
durat
pulmonari
sign
bronchiol
md
day
ci
p
compar
patient
receiv
ribavirin
studi
also
examin
outcom
shown
tabl
laggera
pterodonta
random
trial
examin
laggera
pterodonta
assess
durat
hospit
studi
n
show
patient
elig
discharg
third
day
admiss
compar
placebo
group
rr
ci
p
studi
also
show
significantli
lower
clinic
sever
score
throughout
hospit
stay
among
patient
receiv
laggera
pterodonta
effect
estim
calcul
due
lack
data
origin
studi
studi
also
examin
outcom
shown
tabl
ephedracontain
herbal
decoct
follow
two
studi
evalu
outcom
hospit
length
stay
first
cohort
studi
feng
et
al
n
author
found
higher
cure
rate
patient
administ
oral
liquid
jie
jing
ding
chuan
zhi
xiao
tang
formul
rr
ci
p
cohort
studi
n
examin
effect
inhal
xiao
er
zhi
chuan
tang
adjuv
usual
care
herbal
formul
found
shorten
durat
respiratori
symptom
cough
md
day
ci
p
fever
md
day
ci
p
dyspnea
md
day
ci
p
chest
wall
retract
md
day
ci
p
rale
md
day
ci
p
wheez
md
day
ci
p
result
higher
cure
rate
rr
ci
p
compar
convent
treatment
studi
also
examin
outcom
shown
tabl
supplement
mechan
action
supplement
shown
tabl
vitamin
one
random
trial
n
examin
effect
vitamin
supplement
bronchiol
author
found
vitamin
effect
placebo
reduc
hospit
length
stay
md
hour
ci
p
durat
bronchiol
symptom
md
hour
ci
p
durat
feed
problem
md
hour
ci
p
studi
also
examin
outcom
shown
tabl
nacetylcystein
random
trial
n
naz
colleagu
nacetylcystein
show
signific
benefit
length
hospit
stay
md
day
ci
p
compar
salbutamol
patient
receiv
nacetylcystein
show
better
improv
clinic
sever
score
receiv
salbutamol
md
ci
p
zinc
random
trial
n
conduct
gupta
collabor
oral
zinc
report
benefici
effect
outcom
length
hospit
stay
togeth
two
trial
zinc
show
benefit
manag
clinic
symptom
bronchiol
tabl
latter
two
studi
assess
outcom
length
hospit
stay
magnesium
two
studi
evalu
magnesium
either
alon
adjuv
therapi
bronchiol
infant
studi
modaresi
cowork
n
found
signific
differ
durat
hospit
md
ci
p
magnesiumtr
patient
convent
treatment
group
howev
magnesium
treatment
associ
significantli
better
improv
clinic
sever
score
compar
epinephrin
tabl
threearm
random
trial
kose
et
al
n
signific
differ
observ
durat
hospit
group
magnesiumsalbutamol
vs
magnesium
vs
hour
salbutamol
p
inhal
magnesium
salbutamol
combin
result
lower
clinic
sever
score
compar
treat
salbutamol
md
ci
p
magnesium
alon
md
ci
p
advers
event
five
total
eleven
studi
provid
inform
advers
event
ae
kose
et
al
report
ae
hypotens
arrhythmia
loss
deep
tendon
reflex
patient
treat
inhal
magnesium
sulfat
monotherapi
salbutamol
monotherapi
salbutamolmagnesium
sulfat
combin
therapi
likewis
naz
et
al
note
patient
treat
inhal
nacetylcystein
experienc
side
effect
includ
stomat
rhinorrhea
nausea
gastrointestin
disturb
two
studi
examin
oral
laggera
pterodonta
mixtur
oral
zinc
suspens
report
higher
incid
vomit
diarrhea
placebo
group
one
studi
report
differ
incid
diarrhea
infant
receiv
oral
vitamin
drop
placebo
best
knowledg
first
systemat
review
examin
effect
safeti
complementari
altern
medicin
cam
treatment
bronchiol
review
found
two
studi
report
signific
benefit
associ
use
cam
primari
outcom
length
hospit
stay
first
studi
n
cohort
studi
conduct
wang
et
al
report
chines
herbal
medicin
shuang
huang
lian
reduc
durat
hospit
day
compar
ribavirin
second
studi
n
random
control
trial
undertaken
saad
et
al
demonstr
vitamin
decreas
length
stay
day
compar
placebo
contrari
nacetylcystein
zinc
magnesium
benefit
length
hospit
stay
studi
chines
herbal
medicin
vitamin
nacetylcystein
magnesium
show
benefit
respect
clinic
sever
score
oxygen
satur
symptom
resolut
nonetheless
find
primari
studi
interpret
cautious
given
heterogen
across
trial
cam
treatment
studi
outcom
report
differ
trial
design
conduct
well
insuffici
case
lack
rigor
evid
differ
intervent
eg
studi
herbal
medicin
cohort
studi
singl
studi
mani
cam
intervent
small
sampl
size
current
american
academi
pediatr
aap
guidelin
recommend
apart
length
hospit
stay
parent
satisfact
patientcent
outcom
integr
evalu
effect
pharmacotherapi
bronchiol
studi
identifi
review
report
patientcent
outcom
instead
number
studi
especi
examin
herbal
decoct
use
cure
rate
global
assess
outcom
uncertain
criteria
establish
definit
uniform
across
studi
furthermor
current
univers
valid
bronchiol
score
system
clinic
practic
review
kose
et
al
use
clinic
sever
score
css
tool
develop
wang
et
al
wherea
modaresi
et
al
use
respiratori
distress
assess
instrument
rdai
measur
albeit
two
studi
analog
examin
magnesium
use
differ
clinic
sever
score
tool
predict
cours
ill
may
affect
treatment
outcom
due
dissimilar
paramet
assess
variabl
measur
report
outcom
across
studi
bronchiol
preclud
formal
metaanalysi
find
provid
evid
inconsist
problem
outcom
report
sourc
bia
literatur
need
assess
outcom
across
cam
studi
howev
systemat
assess
treatment
efficaci
often
complic
wide
rang
outcom
measur
use
investig
therefor
necessari
agre
core
outcom
set
measur
report
futur
studi
assess
impact
cam
bronchiol
agenc
healthcar
research
qualiti
ahrq
recommend
futur
studi
ascertain
clinic
relev
outcom
particularli
rate
hospit
need
intens
servic
hospit
cost
care
parent
satisfact
treatment
develop
longerterm
respiratori
problem
facilit
clariti
commun
outcom
increas
valu
exist
futur
data
also
potenti
concern
find
review
may
subject
public
bia
often
difficult
detect
systemat
review
studi
due
heterogen
outcom
assess
method
report
variou
type
cam
use
assess
public
bia
perform
henc
unabl
rule
presenc
public
bia
bodi
literatur
scarciti
inform
concern
qualiti
well
complet
constitu
herbal
prepar
use
key
reason
could
difficulti
standard
herbal
prepar
manifold
constitu
natur
age
plant
harvest
season
sourc
locat
techniqu
crude
prepar
may
affect
chemic
composit
potenc
herb
deriv
although
manufactur
commenc
standard
herbal
product
still
gener
lack
consist
market
hand
research
supplement
encumb
absenc
reliabl
assay
detect
micronutri
defici
instanc
emerg
vitamin
assay
preliminari
competit
protein
bind
assay
immunoassay
liquid
chromatographytandem
mass
spectrometri
assay
shown
numer
analyt
challeng
immunoassay
popular
method
consider
eas
use
cost
rapid
howev
accuraci
specif
remain
issu
discuss
nonexist
reliabl
assay
ad
challeng
elucid
nutrientrel
condit
theori
pharmacodynam
pharmacokinet
miner
supplement
bronchiol
anoth
issu
lack
advers
event
report
less
half
includ
studi
report
advers
event
two
report
advers
event
advers
event
document
gastrointestin
problem
associ
use
laggera
pterodonta
mixtur
vitamin
zinc
scarciti
report
consid
report
bia
could
underestim
magnitud
problem
empir
evid
indic
advers
event
inadequ
report
cam
trial
necessari
improv
report
harm
enabl
accur
object
comprehens
safeti
data
given
user
even
observ
advers
event
potenti
theoret
advers
effect
may
stem
biolog
activ
constitu
herb
side
effect
contamin
crossallergen
camdrug
interact
exampl
three
herbal
prepar
locat
review
contain
ephedra
herba
activ
ingredi
ephedrin
common
side
effect
ephedrin
includ
nausea
vomit
psychiatr
autonom
symptom
palpit
none
report
includ
studi
therefor
studi
safeti
prepar
warrant
especi
pertain
camdrug
interact
well
riskbenefit
assess
thu
far
find
evid
systemat
review
metaanalys
cam
bronchiol
cochran
review
examin
therapeut
effect
tradit
chines
herbal
medicin
commonli
use
china
acut
bronchiti
nevertheless
find
consist
cochran
review
aspect
sparsiti
avail
evid
need
futur
welldesign
rct
adequ
power
order
formul
clinic
conclus
use
cam
strength
review
includ
literatur
search
use
five
relev
electron
databas
without
languag
restrict
sever
limit
must
address
studi
shortcom
studi
design
outcom
report
moreov
presenc
report
bia
may
caus
concern
current
studi
publish
asia
previous
shown
produc
larg
proport
studi
posit
outcom
outcom
report
primari
studi
ascertain
accord
diseas
sever
may
impact
effect
outcom
studi
deng
et
al
also
compar
chines
herbal
medicin
third
gener
cephalosporin
aminophyllin
oxygen
digitali
frusemid
suggest
presenc
secondari
bacteri
infect
howev
find
evid
sign
diagnosi
bacteri
infect
articl
furthermor
larg
proport
includ
studi
n
report
primari
outcom
interest
systemat
review
albeit
inpati
studi
may
indic
select
outcom
report
potenti
risk
bia
addit
public
bia
recogn
common
phenomenon
clinic
literatur
trial
posit
find
better
chanc
publish
conclus
made
exclus
base
publish
studi
mislead
inclus
publish
articl
review
may
overestim
potenti
benefit
cam
intervent
thu
urg
caution
interpret
anoth
limit
review
search
grey
literatur
includ
confer
abstract
contact
expert
trial
registri
may
miss
studi
relat
limit
recommend
judici
interpret
evid
synthes
review
may
unpublish
studi
neg
result
includ
thu
overestim
effect
cam
intervent
base
studi
identifi
includ
view
sparsiti
evid
area
recommend
neg
inconclus
well
posit
result
publish
otherwis
made
publicli
avail
literatur
provid
evid
base
clinic
decisionmak
facilit
clinician
patient
understand
treatment
effect
ineffect
safe
even
harm
like
parent
use
cam
children
paradigm
continu
rise
particularli
diseas
therapeut
option
avail
current
evid
clinic
studi
scarc
often
methodolog
robust
henc
futur
studi
direct
attent
issu
identifi
review
includ
random
blind
sampl
size
complet
report
safeti
profil
particularli
advers
effect
bodi
system
random
control
trial
would
entail
closer
observ
patient
would
usual
translat
better
qualiti
care
would
normal
occur
gener
popul
welldesign
random
control
trial
consid
gold
standard
judg
benefit
intervent
would
provid
highest
level
evid
interest
potenti
benefit
cam
grow
becom
imper
healthcar
provid
monitor
progress
clinic
literatur
commun
find
patient
compel
evid
avail
physician
remain
judici
regard
use
cam
bronchiol
review
identifi
studi
evalu
effect
safeti
varieti
cam
intervent
among
inpati
bronchiol
five
studi
examin
primari
outcom
hospit
length
stay
four
remain
six
studi
find
signific
benefit
associ
primari
outcom
preliminari
evid
indic
chines
herbal
medicin
mixtur
vitamin
nacetylcystein
magnesium
might
potenti
use
manag
symptom
bronchiol
howev
evid
suffici
rigor
enough
formul
recommend
use
cam
among
studi
report
advers
event
seriou
harm
note
need
conduct
high
qualiti
studi
better
understand
effect
well
safeti
cam
bronchiol
infant
support
inform
